Lee has also been keeping an eye out for suitable growth opportunities. As of Dec 31 2021, SPCH has spent $2.4 million, or 67.8% of the $3.54 million raised during its IPO, to expand its business operations locally and regionally.Aside from the balance of $1.14 million in IPO funds, SPCH has amassed...

A CLINIC belonging to HC Surgical Specialists has been granted a licence by the Ministry of Health to provide a number of Covid-19 tests, announced the group in a midday filing on Wednesday (Feb 16).

THE following companies saw new developments that may affect trading of their securities on Wednesday (Jan 12):

HC Surgical Specialists have reported earnings of $4.6 million for the 1HFY2022 ended Nov 30, 2021. The figure is 7.2% lower than earnings of $5.0 million in the 1HFY2021. Earnings per share (EPS) for the period stood 6.1% lower y-o-y at 3.12 cents. Revenue for the period fell 5.2% y-o-y to $10.4 ...

CATALIST-LISTED HC Surgical Specialists’ 1B1 net profit slipped 7.2 per cent to S$4.6 million from S$5 million the previous year, in part due to a decline in revenue as fewer patients pursued elective medical treatments amid the heightened Covid-19 situation across the half year ended Nov...

HC Surgical Specialists (HCSS) will be acquiring the remaining 49% stake in Jason Lim Endoscopy and Surgery (JLES) for $9 million. Upon completion of the acquisition, HCSS will own 100% of JLES. The acquisition is in line with the group’s long-term plans for growth, and will continue to enhance th...

SHARES of medical services provider HC Surgical Specialists jumped 18.8 per cent or S$0.09 to S$0.57 in early trade on Wednesday, with 225,300 shares changing hands as at 9.29am.

HC Surgical Specialists, which focuses on endoscopic procedures, has reported earnings of $8 million for the full year ended May 31, double from $3.99 million clocked in the preceding year. Revenue in the same period was up 39.7% to $23.36 million, thanks to “pent-up demand” after circuit breake...

CATALIST-LISTED medical services provider HC Surgical Specialists has doubled its dividend, citing uplift from demand for colorectal procedures.

THE following companies saw new developments that may affect trading of their securities on Thursday: